Loading clinical trials...
Loading clinical trials...
Quality of Life of HIV-infected Patients Switched to Raltegravir Versus Other Antiretroviral Regimens
Conditions
Start Date
November 9, 2012
Primary Completion Date
October 31, 2013
Completion Date
October 31, 2013
Last Updated
April 21, 2017
NCT07071623
NCT07115901
NCT07236905
NCT04375800
NCT07209917
NCT05495906
Lead Sponsor
Merck Sharp & Dohme LLC
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions